miRNAs in Gastrointestinal Diseases: Can We Effectively Deliver RNA-based Therapeutics orally?
- 18 November 2019
- journal article
- review article
- Published by Taylor & Francis in Nanomedicine
- Vol. 14 (21) , 2873-2889
Abstract
Nucleic acid-based therapeutics are evaluated for their potential of treating a plethora of diseases, including cancer and inflammation. Short nucleic acids, such as miRNAs, have emerged as versati...Keywords
This publication has 170 references indexed in Scilit:
- An adenoviral vector-based expression and delivery system for the inhibition of wild-type adenovirus replication by artificial microRNAsAntiviral Research, 2013
- Non-condensing polymeric nanoparticles for targeted gene and siRNA deliveryInternational Journal of Pharmaceutics, 2012
- Oral TNF-α gene silencing using a polymeric microsphere-based delivery system for the treatment of inflammatory bowel diseaseJournal of Controlled Release, 2011
- Functional TNFα gene silencing mediated by polyethyleneimine/TNFα siRNA nanocomplexes in inflamed colonBiomaterials, 2011
- Early detection of lung adenocarcinoma in sputum by a panel of microRNA markersInternational Journal of Cancer, 2010
- Polymeric nanoparticles for siRNA delivery and gene silencingInternational Journal of Pharmaceutics, 2009
- Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissuesAdvanced Drug Delivery Reviews, 2009
- Addressing the PEG Mucoadhesivity Paradox to Engineer Nanoparticles that “Slip” through the Human Mucus BarrierAngewandte Chemie International Edition, 2008
- MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon AdenocarcinomaJAMA, 2008
- Altered Expression of miR-21, miR-31, miR-143 and miR-145 Is Related to Clinicopathologic Features of Colorectal CancerOncology, 2007